As a cornerstone therapy for T2DM, GLP-1 receptor agonists (GLP-1RAs) have undergone continuous improvement, culminating in the development of "biased GLP-1RAs," with ecnoglutide serving as an example
A 2024 JAMA Network Open study found that supplementing a GLP-1 receptor agonist with exercise (indoor cycling and circuit training, specifically) can help preserve bone strength
Why All GLP-1 Drugs Face Lawsuits Despite their differences in active ingredients, manufacturers, and mechanisms, all GLP-1 medications share one critical characteristic that makes them dangerous : The Common Mechanism: Delayed Gastric Emptying Normal Digestion: You eat food Your stomach churns and breaks it down (1-2 hours) Partially digested food moves into the small intestine Nutrients are absorbed Waste continues to the colon On GLP-1 Medications: You eat food The drug dramatically slows stomach muscle contractions Food sits in the stomach for many hours (or days) Delayed movement into small intestine Prolonged fullness leads to appetite suppression and weight loss For Most Patients: This causes temporary fullness and reduced appetite - the intended effect
It directly compared outcomes to both placebo and dulaglutide (1.5 mg), establishing proof of concept
Nausea, vomiting, diarrhea, and constipation may occur and are usually due to delayed stomach emptying
Should I take soluble or insoluble fiber on semaglutide
